Loading chat...

TN SB2099

Bill

Status

Passed

4/17/2018

Primary Sponsor

Steven Dickerson

Click for details

Origin

Senate

110th General Assembly

AI Summary

Legislative Description

As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.

Controlled Substances

Last Action

Comp. became Pub. Ch. 674

4/17/2018

Committee Referrals

Calendar3/7/2018
Health and Welfare2/28/2018
Judiciary2/5/2018

Full Bill Text

No bill text available